Search results

Ethos slams Novartis for advisory vote on sustainability report at AGM

16 February 2024

‘There is no doubt’ that a binding vote is necessary, says foundation

Ethos opposes Novartis’ proposal of virtual-only AGMs

21 February 2023

The foundation is in favour instead of ‘hybrid’ AGMs

Swiss 1e pension plans spark appetite for younger generations

21 August 2020

Large companies with 1e solutions include CS and Novartis

Ethos finds shortfalls in Nestlé’s sustainability report

5 April 2024

The company is failing to disclose sufficient detail in particular on Scope 3 emissions

​Swedish pension funds warn companies against digital-only AGMs

20 February 2024

Alecta, AMF, AP funds say will vote down proposals to axe obligation to hold physical shareholder meetings

Novartis misses benchmark

30 May 2007

SWITZERLAND – Novartis’ CHF14.3bn (€8.7bn) pension fund has reported a return of just 2% for 2006 – below both the 6.6% average for other Swiss schemes and its own 3% benchmark.

Large Swiss firms fail to assess impact of digital transformation on workforce

19 December 2023

However, Switzerland’s largest listed companies researched in Ethos study have improved their scores with regard to digital responsibly

Switzerland's Ethos presses for review of Novartis' remuneration policy

22 February 2011

Foundation argued that remuneration should not reward risk-taking.

Ethos plans Novartis revolt

21 February 2007

SWITZERLAND – Socially-responsible manager Ethos says it will oppose the re-election of a senior official at the Swiss pharmaceuticals giant Novartis during the firm’s annual shareholder meeting on March 6.

Oxfam starts Novartis campaign

23 January 2007

UK – Responsible investment campaigners FairPensions and international development agency Oxfam, have asked institutional investors to use their shareholder rights to put pressure on pharmaceutical firms.

New head at €8bn Novartis scheme

10 October 2006

SWITZERLAND – Gino Pfister has stepped down as director of the Novartis pension fund, one of Switzerland’s biggest with CHF14.6bn (€8.6bn) in assets.

CEO commitment on mental health lacking, CCLA global benchmark shows

10 October 2023

There is a clear economic case for investment in mental health at work, says CCLA stewardship lead

Pensionskasse Post boosts infrastructure, real estate investments

29 August 2023

The scheme allocated CHF100m for impact investments in infrastructure

Novartis pension fund returns 6.2%

2 June 2006

SWITZERLAND – Novartis’ pension fund, one of Switzerland’s biggest with CHF14.6bn (€9.3bn) in assets, has reported a return of 6.2% for 2005 - well below the 11% average for other Swiss schemes.

Cometa opposes CEO remuneration, but in favour of labour rights at AGMs

3 March 2023

The Italian pension fund has opposed high pay, or pay not linked to ESG goals, of managers at Siemens, Deere & Co, and Compass Group

Novartis shifts from 'bricks and mortar'

December 2002 (Magazine)

The SFr16.8bn (e11.4bn) pension scheme of Swiss pharmaceutical giant, Novartis, holds real estate assets that comprise 12% of the fund’s assets. Earlier this year, it completed a major transition in the approach to its property portfolio, which allowed the fund to maintain its exposure to this asset class, while enabling ...

A closer look at European equities

Reference Hub1 October 2024By STOXX

Interview with Arun Singhal, Global Head of Product Management at STOXX.

Novartis ready for the euro

May 1998 (Magazine)

Better the equity market devil you know?

June 2023 (Magazine)

Being a large equity investor in a relatively small domestic market can have advantages as well as drawbacks. Proximity to the market and its infrastructure, good knowledge of corporates and corporate leaders, and the ability to exercise strong influence as an owner, potentially a stable long-term one, all count among the advantages. The need to avoid concentration – in terms of position, sizing and overall allocations – and idiosyncratic sector exposure are among the challenges. 

Novartis fund makes move from concrete to paper

January 2002 (Magazine)

Pension funds in Switzerland have a long tradition of investing in property, and the team responsible for the Sfr18bn(e12bn) Novartis pension fund is not exception. The Basle-based pension fund has for years had a significant exposure to real estate, around 12% of the total portfolio, through direct holdings in property, ...